Gourzoulidis George (George Gourzoulidis, George A Gourzoulidis)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Replacement Therapy

Cardiovascular Disease

Small Cell Lung Cancer

Acute Lymphoblastic Leukemia

Top Venues

Clinical drug investigation

Expert review of pharmacoeconomics & outcomes research

Temperature (Austin, Tex.)

This page only lists publications with an associated author ORCID identifier.

Publications

Gourzoulidis George, Oresteia Zisimopoulou, Andrianos Liavas, Charalampos Tzanetakos
Lorlatinib as a first-line treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: Α cost-effectiveness analysis in Greece. Expert review of pharmacoeconomics & outcomes research (2023)
Gourzoulidis George, Argyro Solakidi, Marina Psarra, Eleni Nikitopoulou, Charalampos Tzanetakos
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece. Clinical drug investigation 44 (1) (2023)
Gourzoulidis George, Argyro Solakidi, Marina Psarra, Eleni Nikitopoulou, Charalampos Tzanetakos
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece. Clinical drug investigation (2023)
Sophie Warren, Myrto Barmpouni, Vasiliki Kossyvaki, Gourzoulidis George, Johnna Perdrizet
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants. Vaccines 11 (8) (2023)
Gourzoulidis George, Argyro Solakidi, Marina Psarra, Eleni Nikitopoulou, Charalampos Tzanetakos
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece. Clinical drug investigation 44 (1) (2023)
Gourzoulidis George, Maria Koulentaki, Antonis Kattamis, Maria Bouzani, Chara Giatra, Vassiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba
Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece. Clinical drug investigation (2022)
Gourzoulidis George, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry, Charalampos Tzanetakos, Georgia Kourlaba
Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece. Journal of health economics and outcomes research 9 (1) (2022)
Leonidas G Ioannou, Lydia Tsoutsoubi, Konstantinos Mantzios, Maria Vliora, Eleni Nintou, Jacob Feder Piil, Sean R Notley, Petros C Dinas, Gourzoulidis George, George Havenith, Matt Brearley, Igor B Mekjavić, Glen P Kenny, Lars Nybo, D Andreas Flouris
Indicators to assess physiological heat strain - Part 3: Multi-country field evaluation and consensus recommendations. Temperature (Austin, Tex.) 9 (3) (2022)
Gourzoulidis George, Koulentaki Maria, Kattamis Antonis, Bouzani Maria, Giatra Chara, Chotzagiannoglou Vassiliki, Beletsi Alexandra, Kourlaba Georgia
Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece. Clinical drug investigation 42 (11) (2022)
Leonidas G Ioannou, Petros C Dinas, Sean R Notley, Flora Gofa, Gourzoulidis George, Matt Brearley, Yoram Epstein, George Havenith, Michael N Sawka, Peter Bröde, Igor B Mekjavić, Glen P Kenny, Thomas E Bernard, Lars Nybo, D Andreas Flouris
Indicators to assess physiological heat strain - Part 2: Delphi exercise. Temperature (Austin, Tex.) 9 (3) (2022)
Gourzoulidis George, Maria Koulentaki, Anna Koumarianou, Epaminondas Samadas, Nikolaos Androulakis, Spyridon Xynogalos, Pavlos Papakotoulas, Ioannis Boukovinas, Michalis Karamouzis, John Souglakos, Vasiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece. Expert review of pharmacoeconomics & outcomes research (2021)
Gourzoulidis George, Garyfallia Stefanou, Marina Economou, Sofia Vakalopoulou, George Filippidis, George Soultatis, Dimitrios Kontos, Sotiria Tzima, Fotis Ntemousis, Angeliki Fassa, Georgia Kourlaba
Application of Multicriteria Decision Analysis to Determine the Value of Prophylaxis Relative to On-Demand Treatment in Hemophilia A and Emicizumab versus Replacement Therapy in the Greek Healthcare Setting. Clinical drug investigation (2021)
Gourzoulidis George, Charalampos Tzanetakos, Ioannis Ioannidis, Vasilis Tsimihodimos, Viana Diogo, George Karpouzos, Giannis Papageorgiou, Georgia Kourlaba
Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece. Clinical drug investigation 41 (4) (2021)